X-linked dysmyelinating disorders such as Pelizaeus–Merzbacher disease (PMD) or spastic paraplegia type 2 (SPG2) are typically caused by point mutations in PLP1. This evidence concerns the gene PLP1 and Pelizeaus-Merzbacher spectrum disorder.